MétaCan
Menu
Back to cohort

Abstract 7: Risk of Intracranial Hemorrhage Among Acute Ischemic Stroke Patients Receiving Prior Antiplatelet Therapy and Treated with Intravenous Tissue Plasminogen Activator

2014· article· en· W2249257104 on OpenAlexaff
Ying Xian, Maria Grau-Spulveda, Lee H. Schwamm, Deepak L. Bhatt, Eric E. Smith, Mathew J. Reeves, Jerome J. Federspiel, Laine Thomas, Janet Prvu Bettger, Daniel T. Laskowitz, Adrian F. Hernandez, Gregg C. Fonarow, Eric D. Peterson

Bibliographic record

VenueCirculation Cardiovascular Quality and Outcomes · 2014
Typearticle
Languageen
FieldMedicine
TopicAcute Ischemic Stroke Management
Canadian institutionsUniversity of Calgary
Fundersnot available
KeywordsMedicineStroke (engine)Internal medicineAtrial fibrillationDiabetes mellitusTissue plasminogen activatorIntracerebral hemorrhageDyslipidemiaPopulationFibrinolytic agentLogistic regressionCardiologySubarachnoid hemorrhage

Abstract

fetched live from OpenAlex

Background: Intravenous tissue plasminogen activator (tPA) is known to improve outcomes in ischemic stroke. However, patients receiving long-term antiplatelet therapy may face an increased risk of symptomatic intracranial hemorrhage (sICH) when treated with tPA. While current guidelines allow use of tPA in patients on antiplatelet therapy, there are limited data on the safety of tPA in this population. Methods: Data from 51,922 ischemic stroke patients treated with tPA within 4.5 hours of symptom onset from 1,401 Get With The Guidelines-Stroke hospitals between January 2009 and June 2013 were analyzed. Multivariate logistic regression model with generalized estimating equations approach was performed to evaluate the association of preadmission antiplatelet therapy on sICH risk. Results: Of tPA treated patients 23,232 (45%) were receiving antiplatelet medicine prior to admission. Patients on prior antiplatelet therapy were older (median 76 vs. 68 years, p<.001), had more comorbid illness (CAD/prior MI, prior stroke/TIA, atrial fibrillation, diabetes, dyslipidemia, hypertension and heart failure, all p <.001) but had similar stroke severity (median National Institutes of Health Stroke Scale [NIHSS] 10 vs. 10, p=0.07). Crude rates of sICH were higher in those on prior antiplatelet therapy 5.32% vs. 4.03% (unadjusted OR 1.31, 95% CI 1.20-1.43). Multivariate analysis revealed that prior antiplatelet therapy was an independent predictor of sICH (adjusted OR 1.17, 95% CI 1.06-1.29; adjusted sICH rates 4.93% vs. 4.26%), serious systemic hemorrhage or any tPA complications. These findings were consistent in subgroup analysis of 0-3 hour treatment window. However, there were no significant differences between two groups in mortality, discharge to skilled nursing facility or hospice. In contrast, antiplatelet therapy was associated with favorable ambulatory status at discharge after risk adjustment ( Table ). Conclusion: This study represents the largest clinical experience of the safety of thrombolysis in patients on prior antiplatelet therapy. Despite a higher incidence of sICH, the absolute excess risk appears small (0.67%). These findings support current guideline recommendations regarding use of intravenous tPA in patients on antiplatelet therapy with careful weighing of potential risk and benefit.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.179
Threshold uncertainty score0.965

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.249
Teacher spread0.234 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueCirculation Cardiovascular Quality and OutcomesSame topicAcute Ischemic Stroke ManagementFrench-language works237,207